comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and...
TRANSCRIPT
![Page 1: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/1.jpg)
Comparison of pharmacokinetics and efficacy of oral and injectable medicine
![Page 2: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/2.jpg)
Outline
• Background• Results
– Antibiotics– Non steroidal anti-inflammatory drugs (NSAIDs)– Vitamins
• Conclusions and recommendations
![Page 3: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/3.jpg)
Outline
• Background• Results
– Antibiotics– Non steroidal anti-inflammatory drugs (NSAIDs)– Vitamins
• Conclusions and recommendations
![Page 4: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/4.jpg)
Injections given with sterile and reused equipment worldwide
- 2.0 4.0 6.0 8.0 10.0 12.0
Middle East Crescent
South Asia
Eastern Europe andCentral Asia
China and Pacific
South East Asia
East and Southern Africa
West Africa
South America (highermortality)
Central Europe
South America (lowermortality)
Reg
ions
Number of injections per person and per year
Injections given with non-sterile equipment
Injections given with sterile equipment
![Page 5: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/5.jpg)
Injections: A dangerous engine of disease
• Hepatitis B– Highly infectious virus– Highest number of infections (21 million annually)– 32% of HBV infections
• Hepatitis C– More than 2 million infections each year– More than 40% of HCV infections
• HIV– More than 260 000 infections– Approximately 5% of HIV infections
![Page 6: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/6.jpg)
Simonsen et al. WHO 1999
Reported common conditions leading to injection prescription
• Infections– Fever– Upper Respiratory
Infection/ Ear Infection– Pneumonia– Tonsillitis– Pelvic Inflammatory
Disease– Skin Infections– Diarrhea– Urinary tract infection
• Asthma• Other
– Malaise– Fatigue– Old Age
![Page 7: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/7.jpg)
Reported injectable medicines commonly used
• Antibiotics• Anti-inflammatory agents / Analgesics• Vitamins
Simonsen et al. WHO 1999
![Page 8: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/8.jpg)
Reported factors leading to injection overuse
• Prescriber-associated factors– Perceptions regarding injections – Assumptions about patient`s expectations
• Patient-associated factors– Perceptions regarding injections– Therapeutic expectation
• System issues– Lack of effective oral medications– Financial implications
Reeler et. al. WHO 2000
![Page 9: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/9.jpg)
Stoica et al. SHEA 1999
Reported prescribers’ reasons for the use of injections
• Pharmacokinetics– “Strength” of injectables– Rapid onset of action– Poor intestinal absorption
of oral medications– Absence of effective oral
medications
• Other– Recommendations by
Professors/Ministry of Health
– Direct observed therapy
• Patient care issues– Inability of patient to take
medications by mouth– Patient’s desire for injection– Chronic condition of patient
( illness, malnutrition or alcohol abuse)
![Page 10: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/10.jpg)
Misconceptions about injections among prescribers
• Oral absorption is variable, whereas parenteraladministration assures high drug levels
• Injectable drugs are “stronger” than oral drugs• Injectable drugs have more rapid onset of action• Chronic conditions (malnutrition) of patients leads to
poor oral absorption of drugs
![Page 11: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/11.jpg)
Providers
Misunderstanding between patients and prescribers leading to injection overuse
80-95% of patients do not prefer injections
Over-prescription
Demand
Patients’ perception that providers prefer
injections
5-20% of patients prefer injections
Providers’ perception that patients prefer
injections
![Page 12: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/12.jpg)
Addressing Cognitive Dissonance Using Patient-Provider Interactional Group
Discussions, Indonesia, 1993
0%
20%
40%
60%
80%
100%
1 3 5 7 9 11 13 15 17 19 21 23 25
Months
Prop
ortio
n of
vis
its w
ith in
ject
ion
Control Group
InteractionalGroupDiscussion
Source: Long-term impact of small group interventions, Santoso et al., 1996
![Page 13: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/13.jpg)
Objectives of the Study
• Primary objective– Provide an evidence base for decision making in prescribing
injections
• Secondary objective – Compare pharmacokinetics of oral and injectable drugs– Describe the impact of malnutrition on drug
pharmacokinetics– Compare the effectivenesss of oral and injectable drugs in
randomized clinical trials– Compare the cost of oral and injectable drugs
![Page 14: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/14.jpg)
Literature review methods
• Medline• Cochrane reviews• Pharmacology textbook reviews• Micromedex
![Page 15: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/15.jpg)
Outline
• Background• Results
– Antibiotics– Non steroidal anti-inflammatory drugs (NSAIDs)– Vitamins
• Conclusions and recommendations
![Page 16: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/16.jpg)
Parameters commonly used in pharmacokinetics
• Parameters affected by mode of administration– Absorption– Bio-availability– Peak serum concentration– Time to peak serum concentration
• Parameters unaffected by mode of administration– Half-life – Clearance– Distribution– Metabolism– Protein binding
![Page 17: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/17.jpg)
IV 100% bioavailable
Factors influencing absorption and bioavailability of medications
• Oral route– Food consumption– Cation interaction– Gastric pH– Intrinsic absorptive
capabilities of digestive tract
– First pass hepatic metabolism
• IM route– Injection site– Diluent– Solubility of drug– Concentration of drug– Total surface area for
diffusion– Blood flow to muscle
injected
![Page 18: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/18.jpg)
Outline
• Background• Results
– Antibiotics– Non steroidal anti-inflammatory drugs (NSAIDs)– Vitamins
• Conclusions and recommendations
![Page 19: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/19.jpg)
Peak serum concentration of selected oral, IM and IV antibiotics
Class of Antibiotic Oral IM IV
Natural Penicillin ++ - +++++
Aminopenicillin + ++ +++
Fluoroquinolones + NA +
Chloramphenicol ++ + ++
Sulfonamides + NA +
Rifampin + NA ++
Source: Micromedex
![Page 20: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/20.jpg)
Time to peak serum concentration by different modes of administration
• Oral– 30min – 6hrs
• IM – 30min – 3hrs*
• IV– End of infusion
* Natural penicillin time to peak serum concentration 4-24 hrs
![Page 21: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/21.jpg)
Effect of malnutrition on the pharmacokinetics of antibiotics
• Children– Decreased clearance– Larger area under the curve– Potential toxicity
• Adults – Lower absorption (may be overcome by larger doses)– Increased clearance– Potential need for more frequent administration
![Page 22: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/22.jpg)
Injected and oral antibiotics in the treatment of mild to moderate infections
Clinical outcome Bacterial outcome
No. ofstudies
Studiesreporting equivalence
Studiesreporting parenteral
benefit
Studiesreporting equivalence
Studiesreporting parenteral
benefit
Otitis media 4 4/4 0/4 NA NA
Pneumonia 3 2/3 1/3* 0/1 1/1*
STD 13 2/2 0/2 12/12 0/12
UTI 5 3/3 0/3 2/3 0/3
Osteo-myelitis
2 1/1 0/1 2/2 0/2
*Only in subset of study patients
![Page 23: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/23.jpg)
Sequential and prolonged parenteral antibiotics in the treatment of severe infections
Clinical outcome Bacterial outcome
No. ofstudies
Studiesreporting
equivalence
Studiesreportingparenteral
benefit
Studiesreporting
equivalence
Studies reportingparenteral
benefit
UTI 2 2/2 0/2 1/2 0/2
Pneumonia 3 3/3 0/3 2/2 0/2
Skin infection 2
1/2 0/2 2/2 0/2
Febrilecytopenia
2 2/2 0/2 1/1 0/1
Mixed 4 4/4 0/4 4/4 0/2
![Page 24: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/24.jpg)
Compared cost of selected oral and parenteral antibiotics
DrugRelative cost of parenteral:oralper equivalent
DoseAmpicillin 3:1Cloxacillin 4:1Chloramphenicol 5:1
![Page 25: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/25.jpg)
Outline
• Background• Results
– Antibiotics– Non steroidal anti-inflammatory drugs (NSAIDs)
– Vitamins
• Conclusions and recommendations
![Page 26: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/26.jpg)
Class NSAID Bioavailability(%)
Time to serum peak(hours)
Oral IM Oral IMSalicylic Aspirin 80-100 NA1 0.5-3 NA
LysineAcetylsalicylate --- NA 1-2 0.25
Indolic Indometacin 90-100 NA 0.5-2 NAKetoprofen 95-100 NA 0.5-2 0.3-0.5Ibuprofen 80 --- 2 ---Diclofenac Na 100 100 1.5-3 0.3Ketorolac 80-100 100 0.3-1 0.5-1
Aryl-carboxylic
Naproxen 100 --- 1-2 ---Piroxicam 100 --- 3-5 NAIsoxicam 100 100 10 3
Oxicam
Meloxicam 89 --- 1 NAFenamatesNiflumic ac. --- --- 2 ---
Pyrazolic Phenylbutazone 100 --- 2-5 NA
Comparison of the phamacokinetics of different NSAIDs by route of administration
![Page 27: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/27.jpg)
Authors Diagnosis Oral dosage andfrequency
Injectabledosage andfrequency
Conclusions
Comb Rheumatoidarthritis
Meloxicam Meloxicam IM Both effective and well-tolerated
Auvinet Acute Sciatica Meloxicam Meloxicam IM Both effectiveTurner Pain after surgery R. indometacin Ketorolac IM No significant difference in painShresta Acute gout Indometacin Ketorolac IM Both similar in the reliefKumara Molar surgery Tenoxicam Tenoxicam IV Both equally effectiveTuomilehto Adenoidectomy Ketoprofen Ketoprofen No differences in pain scores,
Supervia Renal colic Piroxicam, Diclofenac IM No significant difference
Evans Ductus arteriosus Indometacin Indometacin IV Intravenous form superior
Randomized clinical trials comparing the outcome of oral and injectable NSAIDs in
various clinical situations
![Page 28: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/28.jpg)
Outline
• Background• Results
– Antibiotics– Non steroidal anti-inflammatory drugs (NSAIDs)– Vitamins
• Conclusions and recommendations
![Page 29: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/29.jpg)
Pharmacokinetics of selected vitamins
Oral Administration IM Administration Absorption Time to
peak serum conc.
Absorption Time to peak serum
conc. Vitamin B6 Well 1.25hrs ? ?
Vitamin B12 Well 8-12 hrs ? 1 hr
Vitamin K Well 6-12 hrs Well 1-2 hrs
Source: Micromedex
![Page 30: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/30.jpg)
Compared outcomes of oral and IM administration for selected vitamins
NA0B6
1 / 2 *2K
1/1 @1B12
OutcomeEqual Oral and IM
Number of StudiesVitamin
@ clinical outcome *Markers of Vitamin K status
![Page 31: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/31.jpg)
Outline
• Background• Results
– Antibiotics– Non steroidal anti-inflammatory drugs (NSAIDs)– Vitamins
• Conclusions and recommendations
![Page 32: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/32.jpg)
Conclusions (1)
• There is minimal to no benefit of IM versus oral administration of drugs in terms of pharmacokinetics
• IV administration results in shorter onset of action and for some drugs higher bioavailability and peak serum levels
• The issue of onset of action is clinically relevant only in life threatening illness
![Page 33: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/33.jpg)
Conclusions (2)
• Normal drug dosing in malnourished children may lead to toxic drug levels
• Undernourished adults may need drug dosing at the high end of the therapeutic range given more frequently
• The pharmacokinetic advantage of parenteral over oral drugs does not translate to better clinical outcomes in mild-moderate illness
• Even in serious illnesses, sequential therapy within 2-5 days can be as effective as prolonged parenteralcourses
![Page 34: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/34.jpg)
Recommendations:indication for therapeutic injections
• Serious and life-threatening illness• Inability to swallow• Profuse vomiting• Absence of effective oral agent• Significantly altered absorption pattern
![Page 35: Comparison of pharmacokinetics and efficacy of oral … of pharmacokinetics and efficacy of oral and injectable medicine. Outline • Background • Results – Antibiotics – Non](https://reader030.vdocument.in/reader030/viewer/2022021509/5aa06d6d7f8b9a0d158e29b0/html5/thumbnails/35.jpg)
Avoid unnecessary injections